Pictet Asset Management (Switzerland)’s CytomX Therapeutics CTMX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-660,495	Closed	-$1.21M	–	1570
2022 Q2	$1.21M	Buy	660,495 +307,380	+87%	+$563K	﹤0.01%	1017
2022 Q1	$943K	Buy	353,115 +64,789	+22%	+$173K	﹤0.01%	1055
2021 Q4	$1.25M	Buy	+288,326	New	+$1.25M	﹤0.01%	1050